Insulin Resistance Is Not One Thing

Insulin resistance is one of the most frequently used phrases in medicine and one of the least precise. We use it as though it names a single problem. It does not. Insulin performs dozens of jobs throughout the body, and resistance to it looks different in every organ. In any given tissue, some insulin signals fail while others continue to work normally. Recognizing that changes how the condition should be understood, and why treating it narrowly falls short.

First, the plain version. Insulin is the hormone the pancreas releases after a meal. It instructs cells to pull glucose from the blood and it governs how the body stores fat. Resistance is usually described as cells no longer responding to insulin. The reality is more specific: the insulin message still reaches the cell, but only some of the responses downstream of that message fail.

The liver: producing fat and glucose at once

In the liver, insulin normally sends two instructions: stop producing glucose, and store some energy as fat. In insulin resistance, the liver ignores the first while continuing to obey the second. It keeps releasing glucose into the blood, a process called gluconeogenesis that insulin is supposed to switch off, and at the same time it increases fat production, called lipogenesis. The same hormone, in the same organ, drives two harmful outcomes at once. Brown and Goldstein named this selective insulin resistance and placed it at the center of the condition [1], and Guo described the tissue-specific signaling behind it [4]. It also explains a pattern clinicians see constantly: high blood glucose and a fatty liver in the same person.

The muscle: lipid blocking the signal

Skeletal muscle is the body's largest destination for blood glucose, and it is often the first site where resistance appears, before the liver falters. When fat accumulates inside muscle cells, a state called intramyocellular lipid, it interferes with the signaling cascade insulin uses to tell muscle to take up glucose. The receptor still binds insulin, but the message stalls partway down the line, and glucose remains in the bloodstream. Shulman's work on the cellular mechanisms of insulin resistance documented this directly [3], and Samuel and Shulman later tied the muscle and liver versions together through ectopic fat [2]. This muscle-level breakdown is among the earliest measurable signs that metabolism is moving in the wrong direction.

The fat tissue: inflamed and leaking

Adipose tissue is not a passive storage tank; it is an active organ, and it behaves poorly when overloaded. When fat cells fill past their comfortable limit, the immune system treats them almost like an injury and surrounds them with chronic, low-grade inflammation. That inflammation interferes with one of insulin's key jobs in fat, which is holding stored fat in place. The fat cells continue taking up sugar and storing it, yet they also leak fatty acids back into the blood even when insulin is high and should be signaling them to hold on [2][4]. Those circulating fatty acids then travel to the liver and muscle, where they deepen the fat accumulation already driving resistance there. The problem reinforces itself.

The brain: the meal that does not register

Insulin also reaches the brain, where it carries a different message: you have eaten, you can stop feeling hungry. The hypothalamus, the brain's appetite-control center, normally reads that signal through an internal pathway built around an enzyme system called PI3K and turns hunger down. In insulin resistance, insulin still reaches those neurons, but the pathway that should relay the message of fullness is impaired, so the brain never fully registers the meal. Gerozissis reviewed this brain-insulin signaling and its role in energy balance [5]. Appetite stays switched on after eating, which makes overeating easier and weight loss harder.

The common thread, and what medicine misses

Note the pattern across all four organs. Insulin, the messenger, still arrives. What breaks is everything downstream of the message, and it breaks selectively, with different pathways failing in different tissues. Insulin resistance is less a single failure than a collection of tissue-specific malfunctions that share a root in excess energy, fat stored where it does not belong, and inflammation [2].

This matters for treatment. Modern medicine largely handles insulin resistance as a blood-glucose problem: lower the glucose number and consider it managed. That approach overlooks the liver quietly producing fat, the adipose tissue leaking fatty acids and fueling inflammation, and the brain that no longer registers a meal. Those organs remain dysfunctional even when the glucose reading appears normal, which is one reason a normal blood sugar can conceal years of trouble, and why we argue for monitoring fasting insulin instead. Real metabolic care has to treat the whole system, the misplaced fat, the inflammation, and the energy excess driving all of it, rather than the single lab value that happens to be easiest to chart. It also points back to the mitochondria, the cellular engines whose struggle to burn fuel ties many of these threads together.

See how our metabolic program works

References

1. Brown MS, Goldstein JL. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab. 2008. PMID: 18249166
2. Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012. PMID: 22385956
3. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest. 2000. PMID: 10903330
4. Guo S. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol. 2014. PMID: 24281010
5. Gerozissis K. Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies. Eur J Pharmacol. 2008. PMID: 18407262